ZEISS Medical Technology showcases the latest innovations and enhancements to its cataract and corneal refractive workflow solutions, from diagnostics and surgical planning to advanced treatments, at the European Society of Cataract and Refractive Surgeons (ESCRS) conference in Copenhagen, Denmark, from Sept. 12-15, 2025.
International medical imaging IT and cybersecurity company Sectra will provide its enterprise imaging solution as a fully managed cloud service, Sectra One Cloud, to a leading medical center in the US. This will enhance workflows within the medical center's radiology, breast imaging, cardiology and orthopaedic departments, while strengthening security and scalability.
Albertsons® Companies, Inc. pharmacies are making it easier and more rewarding than ever for customers to help protect their health this respiratory virus season. Available now, shoppers can receive flu, pneumonia or respiratory syncytial virus (RSV) immunizations at any of the company’s more than 1,700 pharmacy location, including Albertsons, Safeway, Vons, Jewel-Osco, Shaw’s, ACME and Tom Thumb.
A Legionnaires' disease outbreak in Central Harlem has sickened at least 67 people and claimed three lives, raising serious concerns about building safety and water system oversight. According to the New York City Health Department, the outbreak has been linked to 11 rooftop cooling towers that tested positive for Legionella, a waterborne bacteria that can cause serious illness when inhaled through contaminated water vapor.
Rejuva Fresh® LLC, a top United States developer in the aesthetic medical device industry, introduces new enhancements for EMSHAPE® NEO PLUS, a revolutionary powerful technology that makes non-invasive body contouring practically effortless.
Dr. Noaman Sanni, a leading ophthalmologist and CEO of Center for Sight New York, has witnessed significant patient and revenue growth after adding Tixel i into his practice. Tixel i, Novoxel's FDA-cleared device, utilizes patented Thermo-Mechanical Action® (TMA) to effectively treat Meibomian Gland Dysfunction (MGD) – a common cause of dry eye – in under two minutes.
A new article in JOJ Ophthalmology confirms Tixel i® provides sustained, strong clinical outcomes for patients with Evaporative Dry Eye Disease (DED) caused by Meibomian Gland Dysfunction (MGD). This FDA-cleared, non-invasive device uses patented Thermo-Mechanical Action® (TMA®) to deliver durable improvements in key indicators, including patient satisfaction and clinical results.
Alameda Health System (AHS) patients experiencing the sudden and frightening symptoms of a stroke will now receive faster and more-integrated care, thanks to the Wilma Chan Highland Hospital Campus’ (WCHHC) recent certification as a stroke center.
As a leading provider of medical solutions in the field of neurosurgery, ZEISS Medical Technology is also dedicated to shaping modern oncology. The company recently received 510(k) clearance from the US Food and Drug Administration (FDA) for INTRABEAM® 700 – a leading-edge platform that provides robotic-assisted precision to support intraoperative radiation therapy (IORT).
A first in human proof of concept phase I clinical study of VAS-101 (Vasceptor®; topical curcumin gel) in sickle cell disease (SCD) is underway. The study is being conducted by the Foundation for Sickle Cell Disease Research (FSCDR) in Hollywood, Florida, under the supervision of the principal investigator, Dr. Gershwin Blyden.